OncoRes Medical

OncoRes Medical

Private
PerthHealthcare & Life Scienceshttps://www.oncoresmedical.com/

Last Round

Private Equity

Feb 12, 2026

Total Funding Raised

$33.28M

Company Overview

OncoRes Medical is a medical device company developing a handheld, real-time, intraoperative imaging device to improve the detection of residual tumors during breast-conserving surgery.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Precision Medicine, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription, Government Contracts

AI Layer

Non-AI

Keywords

quantitative micro-elastographyQMEintraoperative imagingsurgical margin assessmentre-excision reductionbreast-conserving surgerylumpectomy guidancetissue stiffness imagingsurgical guidance systemoptical coherence tomographyOCTmicro-elastographysurgical oncologyMedTechFDA breakthrough device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

OncoRes Medical Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

OncoRes Medical Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
Private EquityFeb 12, 2026
Series A ExtensionMay 18, 2022
GrantMay 18, 2022
GrantJan 22, 2021
GrantJul 22, 2020
Series A
Jun 2, 2017

Key People

Founding team and executive leadership

Katharine Giles

Managing Director CEO

Executive Team

Simon Graindorge

Chief Operating Officer

Executive Team

OncoRes Medical Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 16, 2026

    Monthly visitors grew 1252% MoM, reaching 4.7K.

OncoRes Medical Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

OncoRes Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about OncoRes Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersPerth
Employee Range43
Year Founded2016
Last FundingFeb 12, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.